Src family kinase-mediated negative regulation of hematopoietic stem cell mobilization involves both intrinsic and

Jovencio Borneo1, Veerendra Munugalavadla, Emily C Sims

  • 1Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Abstract

Insights

Src kinases enhance stem cell mobilization by influencing both intrinsic cell factors and the microenvironment. Targeting these kinases may offer new ways to control stem cell release.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Signaling

Background:

  • Granulocyte colony-stimulating factor (G-CSF) receptor signaling is crucial for stem cell mobilization.
  • The precise intracellular signals mediating G-CSF-induced stem cell release remain incompletely understood.

Purpose of the Study:

  • To investigate the role of Src family kinases (SFKs) in G-CSF-mediated stem cell mobilization.
  • To elucidate the molecular mechanisms underlying SFK involvement in stem cell release.

Main Methods:

  • Utilized genetically modified mice lacking SFK expression (SFK-/-).
  • Analyzed G-CSF-induced stem cell mobilization in wild-type and SFK-/- mice.
  • Performed proteomic analysis of bone marrow fluid.
  • Conducted stem cell transplantation experiments.

Main Results:

  • SFK-/- mice exhibited enhanced G-CSF-induced stem cell mobilization.
  • SFK deficiency led to hypersensitivity of bone marrow cells to G-CSF and sustained STAT3 activation.
  • Proteomic analysis revealed altered protein profiles, increased matrix metalloproteinase-9, reduced SDF-1, and enhanced VCAM-1 breakdown in SFK-/- mice.
  • Stem cell mobilization was greatest in mice completely lacking SFKs, indicating a significant role.

Conclusions:

  • Src kinases play a critical role in both intrinsic hematopoietic and microenvironmental regulation of stem cell mobilization.
  • SFKs are identified as potential therapeutic targets for modulating stem cell mobilization processes.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...